Concert Pharmaceuticals - Building Better Medicinse
Home About Us Research & Development News Careers Contact Us
News
 

Overview

Press Releases

Events

 
 

Events

Upcoming Events ¦ Past Events ¦ Scientific Presentations

Upcoming Presentations

Cowen and Company 30th Annual Health Care Conference
Monday, March 8, 2010, 2:00 p.m. (ET)
Boston, Massachusetts

2010 Healthcare Conference Presentations

J.P. Morgan 28th Annual Healtcare Conference
Monday, January 11, 2010, 9:00 a.m. (PT)
San Francisco, CA

2009 Healthcare Conference Presentations

Merriman Curhan Ford & Co. 6th Annual Investor Summit 2009
Private Company Panel
Tuesday, November 10, 2009, 2:00 p.m. (ET)
New York, NY

2009 Boston Biotech R&D Conference
Tuesday, October 27, 2009, 1:40 p.m. (ET)
Boston, MA

Thomas Weisel Partners 2009 Healthcare Conefrence
Thursday, September 10, 2009, 10:55 a.m. (ET)
Boston, MA

30th Annual Goldman Sachs Global Healthcare Conference
Private Company Forum
Monday, June 8, 2009, 3:30 p.m. (ET)
New York, NY

Cowen and Company 29th Annual Healthcare Conference
Monday, March 16, 2009, 11:00 a.m. (ET)
Boston, MA

J.P. Morgan 27th Annual Healthcare Conference
Monday, January 12, 2009, 2:00 p.m. (PT)
San Francisco, CA

[ back to top ]

2009 Scientific Presentations

CTP-347: A Deuterated Analog of Paroxetine with Greatly Reduced CYP2D6 Mechanism-Based Inactivation
ISSX 16th North American Regional Meeting
October 18-22, 2009

CTP-347, A Deuterated Paroxetine Analog, Exhibits Reduced Mechanism-Based Inactivation of CYP2D6 in Healthy Women
American College of Clinical Pharmacology’s 38th Annual Meeting
September 13-15, 2009

2008 Scientific Presentations

Pharmacokinetic Characterization of a Deuterated Oxazolidinone
48th Annual ICAAC/IDSA 46th Annual Meeting
October 25-28, 2008

Increased In Vitro Metabolic Stability and In Vivo Exposure In Rats Of Precision-Deuterated Indiplon
ISSX 15th North American Regional Meeting
October 12-16, 2008

CTP-347 is a Potential Treatment for Tamoxifen-Induced Hot Flashes with No Observed CYP2D6 Mechanism-Based Inactivation
The North American Menopause Society (NAMS) 19th Annual Meeting
September 24-27, 2008

Design and Synthesis of Potent Oxazolidinone Antibacterial Agents with Enhanced Pharmacokinetic Properties
31st National Medicinal Chemistry Symposium
June 15-19, 2008

Metabolite Identification of Precision-Deuterated Linezolid
56th Annual Meeting American Society for Mass Spectrometry (ASMS)
June 1 -5, 2008


[ back to top ]

 

 
  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
 
Home     Sitemap